Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 1009–1044
- Headlines
- 5463
- Sources here
- 20
- Companies here
- 24
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
IMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDx
Insight Molecular Diagnostics Inc. Discussions with FDA advance toward expected marketing authorization for GraftAssureDx FDA completes current portion of substantive review in a timely manner Favorable Medicare reimbursement policy issued in July significantly increases GraftAssureDx surveillance testing opportunity Strong head-to-head data drive kitted customer …
Sharemaestro market context Trend signal active 52 weeks +17.3%Inspire Medical Systems (INSP) Is Up 19.8% After Q2 Profit And Higher 2026 Guidance - Has The Bull Case Changed?
Inspire Medical Systems reported a swing to profit in Q2 2026 and raised its full-year 2026 revenue guidance, leading to a 19.8% stock increase. Despite this, the company faces ongoing challenges with the Inspire V rollout, marketing spend, and reimbursement policies. The article questions …
TELA Bio Withdraws 2026 Revenue Guidance as Sales Fall 4%
TELA Bio reported Q2 2026 revenue of $19.3 million, a 4% decline year-over-year, primarily due to lower OviTex PRS volumes and price/mix headwinds. Despite an improved gross margin of 72%, the company's net loss widened to $11.3 million. Following the appointment of a new …
iRhythm Technologies (NASDAQ:IRTC) Stock Price Expected to Rise, Truist Financial Analyst Says
Truist Financial has increased its price target for iRhythm Technologies (NASDAQ:IRTC) from $160 to $168, maintaining a "buy" rating and indicating a potential upside of 34.59%. This positive outlook aligns with a "Moderate Buy" consensus rating from MarketBeat analysts, despite some recent target reductions …
LENSAR (LNSR) shareholders back directors, auditor and annual say-on-pay at 2026 meeting
LENSAR, Inc. held its 2026 annual stockholders meeting where shareholders elected three Class III directors, ratified PricewaterhouseCoopers LLP as the independent registered public accounting firm, and approved executive compensation on an advisory basis. Stockholders also preferred an annual frequency for future say-on-pay votes, which …
How (GKOS) Movements Inform Risk Allocation Models
This article analyzes Glaukos Corporation (NASDAQ: GKOS) using AI models, identifying strong sentiment across all horizons and suggesting an overweight bias. It outlines three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels for different risk profiles. …
IRhythm to Gain From VitalConnect Deal, Rising Margins, Oppenheimer Says
Oppenheimer expects iRhythm Technologies to benefit from its acquisition of VitalConnect, which will add a significant product to its portfolio and is expected to be immediately accretive to margins. The firm reiterates an Outperform rating and a $170 price target for iRhythm, citing potential …
Diluted net income available to common stockholders of InMode Ltd. – HAM:154
This article presents the diluted net income available to common stockholders of InMode Ltd., traded on the Hamburg Stock Exchange under the symbol HAM:154. It indicates that the market was closed with no trades recorded for the period. The data is provided by ICE …
Treace Medical Concepts (NASDAQ:TMCI) Price Target Raised to $5.00 at Truist Financial
Truist Financial has increased its price target for Treace Medical Concepts (NASDAQ:TMCI) from $4.00 to $5.00, while maintaining a "hold" rating, suggesting a potential upside of 10.13%. Despite this, the broader analyst consensus remains "Reduce" with a target of $5.17. The company recently reported …
Boston Scientific CEO Mahoney Buys More Than 200k Shares for $10 Million. What Does This Mean for Investors in 2026?
Michael F. Mahoney, Chairman, President & CEO of Boston Scientific Corporation (NYSE:BSX), purchased 186,240 shares of common stock at $48.34 per share on August 3, 2026. SEC Form 4 filing. Transaction summary Metric Value Transaction value $10.1 million Shares purchased 208,359 Post-transaction shares (total) …
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
TELA Bio, Inc. (TELA) reported a wider-than-expected Q2 loss of $0.2 per share against an estimated loss of $0.17, and missed revenue estimates with $19.29 million compared to a $20.2 million forecast. The company's shares have underperformed the S&P 500 year-to-date, and its Zacks …
Stocks making the biggest moves midday: NetApp, Intel, Apple, Doximity, Verisk Analytics & more
Check out some of the companies making the biggest moves midday: MarineMax — The boat and yacht retailer soared 46% after agreeing to be sold to Blackstone Infrastructure's Safe Harbor Marinas for $53 a share in cash, or $1.5 billion. The deal's expected to …
Securities Fraud Investigation Into CVRx, Inc. (CVRX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
Glancy Prongay Wolke & Rotter LLP has launched a securities fraud investigation into CVRx, Inc. (CVRX) after the company disclosed a civil investigative demand from the U.S. Department of Justice concerning sales and marketing practices, including potential false claims and kickbacks. This news, coupled …
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
QuidelOrtho (QDEL) reported second-quarter 2026 adjusted earnings and revenues that surpassed analyst estimates. Despite this beat, the company lowered its full-year 2026 guidance due to persistent weakness in the China market and a more conservative outlook for the upcoming respiratory season, leading to a …
LivaNova (LIVN) Is Down 7.6% After Swinging Back To Profitability In Q2 2026 - What's Changed
LivaNova (LIVN) reported a significant turnaround in Q2 2026, swinging back to profitability with US$108.57 million in net income and US$390.59 million in sales. This improvement was driven by strong first-half sales of US$752.85 million and a shift from a prior-year loss, strengthening the …
Integer Holdings Q2 Earnings & Revenues Top Estimates, Margins Decline
Integer Holdings reported mixed results for Q2 2026, with adjusted EPS and revenues surpassing estimates, but margins declining. The company's revenues were impacted by product-related headwinds and a strategic exit from the Portable Medical business. Integer Holdings also announced a definitive agreement for KKR …
1 Large-Cap Stock with Solid Fundamentals and 2 Facing Challenges
1 Large-Cap Stock with Solid Fundamentals and 2 Facing Challenges Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging …
Tactile Systems Technology, Inc. Reports Second Quarter 2026 Financial Results
Tactile Systems Technology, Inc. announced strong Q2 2026 financial results, with total revenue increasing 9% year-over-year to $85.7 million and net income rising to $7.8 million. The company also reported expanding its gross margin to 76% and increasing Adjusted EBITDA to $11.4 million. Key …
Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Healthcare Innovator with a 12.53% Upside Potential
Smith & Nephew SNATS, Inc. (SNN) is a healthcare innovator with a robust market presence and promising growth potential, offering a 12.53% upside potential based on analyst ratings. The company boasts strong financial health with over $1 billion in free cash flow, 4.60% revenue …
Inogen Q2 Earnings Beat Estimates, Sales Rise Y/Y, 2026 View Cut
Inogen (INGN) reported breakeven earnings for Q2 2026, surpassing estimates, with revenues rising 3% year-over-year to $95.1 million, driven by strong international demand and new products. Despite this, the company cut its full-year 2026 revenue guidance to $355-$361 million, down from previous estimates, due …
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised
iRhythm Holdings, Inc. IRTC reported adjusted earnings per share of 58 cents in the second quarter of 2026, against an adjusted loss per share of 32 cents a year ago. The figure beat the Zacks Consensus Estimate by 5900%. GAAP loss per share for …
Deal Valued At $1.1 Billion Sends This X-Ray Stock Soaring 48%
Varex Imaging soared 48% after Teledyne Technologies said it will buy the company for about $1.1 billion. Teledyne stock held above a buy point. Continue Reading
Senseonics Q2 results: $14.5M revenue, raised guidance
Senseonics Holdings reported a strong Q2 2026 with revenue surging 120% year-over-year to $14.5 million, driven by robust U.S. sales and expanded gross margins of 59%. The company subsequently raised its full-year 2026 revenue guidance to $62-$66 million and gross margin guidance to 58-61%. …
Sotera Health Company (SHC) Reported Positive Results Amid Litigation Wins
US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …
Stocks Pressured as Higher Crude Price Boosts T-Note Yields
The S&P 500 Index ($SPX) (SPY) today is down -0.04%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.15%. September E-mini S&P futures (ESU26) are down -0.04%, and September E-mini Nasdaq futures (NQU26) …
Star Holdings (STHO) Trades at Discount as Fundamental Outperformance Accelerates
US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …
Why iRhythm (IRTC) Shares Are Trading Lower Today
Shares of iRhythm Technologies (IRTC) fell after an analyst significantly cut their price target on the stock, despite the company reporting strong quarterly earnings and raising its full-year revenue guidance. Truist lowered its price target to $18 from $160, even while maintaining a "Buy" …
QuidelOrtho Corporation (QDEL) Stock Positioned for Reweighting Towards Peers Amid Deleveraging
US-based investment company McIntyre Partnerships delivered flat performance in H1 2026, returning 0% gross and -1% net compared to the Russell 2000 Value Index's 23% return. A copy of the letter can be downloaded here. The second quarter results were a complete reversal of …